Functional Genomic Landscape of Human Breast Cancer Drivers, Vulnerabilities, and Resistance

Area of Science:

• Genomics
• Cancer Biology
• Drug Discovery

Background:

• Large-scale genomic studies have revealed numerous somatic aberrations in breast cancer, such as copy number alterations and point mutations.
• Identifying causal variants and emergent vulnerabilities resulting from genetic alterations presents a significant challenge in breast cancer research.

Purpose of the Study:

• To identify novel breast cancer vulnerabilities and functional genomic properties using genome-wide shRNA dropout screens.
• To integrate screening data with genetic and proteomic information to uncover candidate driver genes.
• To explore potential therapeutic strategies, including drug resistance mechanisms and combination therapies.

Main Methods:

• Performed whole-genome small hairpin RNA (shRNA) dropout screens across 77 breast cancer cell lines.
• Utilized a hierarchical linear regression algorithm to score screen results.
• Integrated screening data with comprehensive genetic and proteomic information.

Main Results:

• Identified key vulnerabilities and candidate driver genes in breast cancer.
• Revealed general functional genomic properties of cancer cells.
• Linked gene essentiality data with drug sensitivity, suggesting resistance mechanisms and combination therapy opportunities.
• Identified BRD4 as a potential therapeutic target in luminal breast cancer.
• Found PIK3CA mutations to be a resistance determinant for BET-inhibitors.

Conclusions:

• This study provides a valuable dataset for understanding breast cancer functional genomics and identifying therapeutic targets.
• BRD4 emerges as a potential target for luminal breast cancer treatment.
• PIK3CA mutations confer resistance to BET-inhibitors, informing future therapeutic strategies.